Correlation Between ETFS Ultra and ETFS SP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ETFS Ultra and ETFS SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ETFS Ultra and ETFS SP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ETFS Ultra Short and ETFS SP Biotech, you can compare the effects of market volatilities on ETFS Ultra and ETFS SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ETFS Ultra with a short position of ETFS SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of ETFS Ultra and ETFS SP.

Diversification Opportunities for ETFS Ultra and ETFS SP

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between ETFS and ETFS is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding ETFS Ultra Short and ETFS SP Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ETFS SP Biotech and ETFS Ultra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ETFS Ultra Short are associated (or correlated) with ETFS SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ETFS SP Biotech has no effect on the direction of ETFS Ultra i.e., ETFS Ultra and ETFS SP go up and down completely randomly.

Pair Corralation between ETFS Ultra and ETFS SP

Assuming the 90 days trading horizon ETFS Ultra Short is expected to generate 2.23 times more return on investment than ETFS SP. However, ETFS Ultra is 2.23 times more volatile than ETFS SP Biotech. It trades about 0.12 of its potential returns per unit of risk. ETFS SP Biotech is currently generating about -0.08 per unit of risk. If you would invest  2,275  in ETFS Ultra Short on December 29, 2024 and sell it today you would earn a total of  465.00  from holding ETFS Ultra Short or generate 20.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ETFS Ultra Short  vs.  ETFS SP Biotech

 Performance 
       Timeline  
ETFS Ultra Short 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ETFS Ultra Short are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, ETFS Ultra unveiled solid returns over the last few months and may actually be approaching a breakup point.
ETFS SP Biotech 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days ETFS SP Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Etf's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the exchange-traded fund private investors.

ETFS Ultra and ETFS SP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ETFS Ultra and ETFS SP

The main advantage of trading using opposite ETFS Ultra and ETFS SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ETFS Ultra position performs unexpectedly, ETFS SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ETFS SP will offset losses from the drop in ETFS SP's long position.
The idea behind ETFS Ultra Short and ETFS SP Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk